INTRODUCTION
============

Following the successful development of structural genomic initiatives dedicated to the determination of the three-dimensional conformation of a large number of proteins ([@B1],[@B2]), attention is now turning to the characterization of the multitude of interactions between these proteins that control cellular processes and biological function ([@B3; @B4; @B5; @B6]). This paradigm, the description of the molecular basis of the interactome, is expected to provide a comprehensive portrayal of the overall interaction structure of an organism\'s proteome, thereby representing one of the major challenges for structural biology in the coming decade ([@B7]). Although very weak protein--protein interactions (dissociation constant *K*~d~ \> 10^−4^ M) are expected to be important for a vast range of cellular events, such as transcription and replication, signal transduction, transient formation of encounter complexes and assembly of protein complexes, they remain the least well characterized ([@B8]).

NMR is one of the most powerful tools for the study of biomolecular complexes due to its sensitivity to protein--protein interactions with equilibrium dissociation constants varying over many orders of magnitude, including weak encounter complexes that can barely be detected using other biophysical techniques ([@B8; @B9; @B10]). In addition to the mapping of chemical shift (CS) changes induced by the proximity of the partner protein, cross-relaxation (nOe)-derived intermolecular distance restraints and paramagnetic relaxation enhancements ([@B9]), residual dipolar couplings (RDCs) ([@B11],[@B12]) have been shown to provide highly complementary orientational information that can be crucial for the determination of an accurate conformation of the complex ([@B13; @B14; @B15; @B16; @B17; @B18; @B19; @B20; @B21]). In the case of weak protein--protein complexes, where orientational constraints can be the most critical due to the insensitivity of NOESY experiments, the use of RDCs is seriously compromised by numerous experimental and theoretical complications. This is essentially because under conditions where the complex is too weak to be isolated experimentally, measured RDCs report on both bound and free forms of the molecule. Alignment characteristics of free and bound forms of both proteins must therefore be determined and alignment levels accurately calibrated.

In this work, we address these problems and present a generally applicable protocol for the measurement, analysis, and interpretation of RDCs for the refinement of the structure of weak protein--protein complexes. The protocol includes differential isotopic labeling of the two proteins ([@B22]) to allow the simultaneous measurement of RDCs at different molar ratios of both partners, and uses a robust linear extrapolation approach to determine the bound form RDCs from partner proteins in the same experimental mixtures. The protocol is shown via entirely independent cross-validation of data not used in the analysis to be highly accurate, and the importance of this methodology is clearly demonstrated by a detailed analysis of the significant structural errors that can be induced when residual components from the free forms of either protein contribute to the measured RDCs.

We apply this approach to the study of the complex formed between SH3-C, the third SH3 domain of CD2AP (CD2-associated protein) and ubiquitin. Ubiquitin is known to regulate a wide variety of cellular activities ranging from transcriptional regulation to cell signaling and membrane trafficking ([@B23],[@B24]). Many cellular activities of ubiquitin are mediated by mono- rather than poly-ubiquitin, and its functions are deciphered by various ubiquitin-binding proteins. Similar to ubiquitin-binding domains, SH3 domains are found in proteins with different biological functions. SH3 domains form a highly conserved family of domains, but their amino acid composition varies at a few key sites, allowing for a wide range of molecular targets. Recently, it was found that a subset of SH3 domains constitutes a new, distinct type of ubiquitin-binding domains ([@B25]). The structure of the complex between Sla1 SH3-3 and ubiquitin shows that the ubiquitin-binding surface of the Sla1 SH3 domain overlaps largely with the canonical binding surface for proline-rich ligands and that like many other ubiquitin-binding motifs, the SH3 domain engages the Ile44 hydrophobic patch of ubiquitin ([@B26]). Here, we use NMR chemical shift perturbation and bound form RDCs for both proteins extrapolated from specifically developed RDC titration experiments, to determine a structural model of the CD2AP SH3-C:Ubiquitin complex.

THEORETICAL ASPECTS
===================

Residual dipolar couplings report on the orientation of internuclear vectors connecting two nuclei *i* and *j* with respect to the alignment tensor of a rigid molecule as follows: *A~a~* and *A~r~* are the axial and rhombic components of the alignment tensors, and *θ*, *φ* define the orientation of the internuclear vector with respect to the alignment tensor and *r~ij~* is the internuclear distance. However, in the case of weak binding and fast exchange between free and bound forms of the proteins, experimental couplings, *D*~*ij*~^exp^, report on a combination of couplings in bound and free forms of the molecule (*D*~*ij*~^bound^ and *D*~*ij*~^free^): where *p*~bound~ is the fraction of the protein in the bound state. In theory, assuming that the ratio of bound and free forms of the proteins is known, *D*~*ij*~^bound^ can be determined using Equation ([2](#M2){ref-type="disp-formula"}) from precise measurements of *D*~*ij*~^exp^ and *D*~*ij*~^free^. Such a procedure has been applied to the study of weakly binding molecules to larger proteins where the nature of the larger system provides *a priori* knowledge allowing a simplification of the problem ([@B18; @B19; @B20; @B21]). Without knowledge of the structure of the complex the contribution of the measured values emanating from the free and bound forms of the proteins can be very difficult to quantitatively separate.

The use of RDCs to determine the relative orientation of partners in weak protein--protein complexes is also severely compromised by additional experimental and analytical difficulties, including the reproduction of identical absolute alignment conditions for the samples necessary for error-free subtraction of the free-form RDCs, and the associated potential for the propagation of experimental uncertainty that is inherent in the necessary subtraction required to derive values of *D*~*ij*~^bound^. RDCs from the bound form of the labeled proteins can of course be isolated under conditions where essentially all of these proteins are bound in the complex, but in the case of weak complexes this saturation limit requires potentially prohibitive concentrations of the partner protein.

We therefore propose a procedure that simultaneously determines the alignment characteristics of both free and bound forms of the proteins, and determines the level of alignment in each medium. Instead of measuring a single mixture, RDCs are measured over a range of titration mixtures *m~i~* of free and bound forms of both proteins. In each of the mixtures the measured RDC, *D*~*ij*~^*m*,exp^, is given by a slightly modified version of Equation ([2](#M2){ref-type="disp-formula"}): where *λ~m~* is a scaling factor defined by the absolute level of alignment that is in turn determined by the concentration of the alignment medium, and *p*~bound~ spans different values for the two proteins. *D*~*ij*~^free^ and *D*~*ij*~^bound^ are given by: *A~a~* and *A~r~* refer to the free or bound alignment tensors, and the two spherical coordinates (*θ*, *φ*) refer to the orientation of the internuclear vector with respect to the alignment tensor in the two forms. Note that this simple linear relationship \[Equation ([3](#M3){ref-type="disp-formula"})\] holds irrespective of changes in structure and dynamics of the site of interest in the complex. For some alignment media *λ~m~* can be estimated from the deuterium quadrupolar coupling from the D~2~O present in the sample. This is not a precise metric however, and it is therefore preferable to exploit the combined dependence of Equation ([3](#M3){ref-type="disp-formula"}) to determine the exact scaling factors, by adjusting *λ~m~* to maintain optimal linearity of *D*~*ij*~^*m*^ relative to *p*~bound~. The same scaling factor is applied to both proteins in the respective mixtures as differential isotope labeling allows simultaneous measurement of RDCs in the two proteins. All couplings from both proteins are used in this procedure ensuring a high level of precision and robustness implicit in this optimization. Following this adjustment the expected values of the bound forms of the RDCs from both proteins are determined from the resulting linear titration relationships established for each individual RDC. This procedure turns out to be highly robust and significantly more accurate than subtraction of a single value scaled on the basis of ^2^D splitting (*vide infra*).

MATERIALS AND METHODS
=====================

Protein expression and purification
-----------------------------------

For clarity, we use the residue numbering of CD2AP SH3-C of PDB entry 2JTE throughout the text. Unlabeled, ^15^N-labeled and ^15^N,^13^C-labeled CD2AP SH3-C was obtained as described ([@B27]). Unlabeled and ^15^N-labeled ubiquitin were purchased from both Cortecnet and Spectra Stable Isotopes. ^15^N/^13^C-labeled ubiquitin was kindly provided by Varian Inc.

Protein concentrations were determined by absorption measurements at 280 nm using an extinction coefficient of 13 980 and 1450 cm^−1^ M^−1^ for SH3-C and ubiquitin, respectively, determined using the ProtParam algorithm ([www.expasy.ch](www.expasy.ch)).

NMR chemical shift perturbation
-------------------------------

All NMR titration experiments were performed at 25°C on a Varian NMR Direct-Drive Systems spectrometer (^1^H frequency of 600.25 MHz) equipped with a triple-resonance PFG-XYZ probe. CD2AP SH3-C and ubiquitin samples were prepared for NMR experiments in 93% H~2~O/7% D~2~O, 50 mM NaPi, 1 mM DTT at pH 6.0. The backbone amide and ^15^N frequencies of CD2AP SH3-C under the above conditions, previously assigned at pH 2.0 ([@B27]), were obtained first by comparing 2D ^15^N-HSQC spectra at pH 2.0, 3.0, 6.0 and 7.0 and confirmed by a single HNCACB triple resonance experiment acquired on ^15^N,^13^C-labeled CD2AP SH3-C at pH 6.0. An HNCACB triple resonance spectrum was also recorded on a ^13^C/^15^N-labeled ubiquitin to confirm backbone assignment at pH 6.0.

The SH3-binding site on ubiquitin was obtained by titrating with increasing amounts of unlabeled CD2AP SH3-C domain into a 0.25 mM ^15^N-ubiquitin sample at pH 6.0, 25°C. Similarly, the ubiquitin-binding site on CD2AP SH3-C was obtained by titrating with increasing amounts of unlabeled ubiquitin into a 0.25 mM ^15^N-SH3-C sample under the same conditions. The progress of the titrations was monitored by recording one-dimensional ^1^H and two-dimensional ^1^H-^15^N HSQC spectra.

The magnitude of the chemical shift deviations (Δδ) was calculated using the equation: where the difference in chemical shift is that between the equilibrium mixture and free forms of the different proteins.

All NMR data were processed using NMRPipe ([@B28]) and analyzed by NMRView ([@B29]).

Measurement of RDCs
-------------------

RDCs were measured in samples partially aligned in a liquid-crystalline medium consisting of a mixture of 5% penta-ethyleneglycol monododecyl ether (C~12~E~5~) and hexanol ([@B30]). For the ^13^C/^15^N-labeled protein (SH3) in the free form or in diverse mixtures of free and complex, a set of four different RDCs (^1^D~NH~, ^1^D~CαC′~, ^2^D~HNC′~ and ^1^D~CαHα~) was measured per sample using 3D BEST-type HNCO or HNCOCA experiments ([@B31],[@B32]). Coupling constants were obtained from line splittings in the ^13^C dimension using the nmrPipe nlinLS fitting routine or using Sparky ([@B33]). For the ^15^N-labeled protein (ubiquitin) in free or in the complex, ^1^D~NH~ were measured from a pair of spin-state-selected ^1^H-^15^N correlation spectra recorded using the pulse sequence shown in figure S4. The pulse sequence uses a DIPSAP filter ([@B34]) for J-mismatch compensated spin-state selection, and the BEST concept for longitudinal relaxation and sensitivity enhancement ([@B31],[@B32]). In addition, signals from the ^13^C/^15^N labeled binding partner are removed by additional transfer steps from ^15^N to ^13^CO. After this transfer step the presence of orthogonal coherences for the spin systems from ^15^N-only and ^13^C/^15^N-labeled proteins is exploited to suppress the unwanted signals by means of pulsed field gradients and phase cycling. Total measurement time for one titration point is ∼1 day.

RDC refinement of the SH3-C domain of CD2AP in complex with ubiquitin
---------------------------------------------------------------------

The program SCULPTOR ([@B35]) has recently been developed as an addition to the program CNS ([@B36]). The refinement protocol involves a restrained MD calculation using the standard CNS force field. Starting structures were taken from a selection of 10 structures determined using HADDOCK ([@B37]) based on ambiguous intermolecular restraints (AIRs). Initial sampling was further increased by including a sampling period of 10 ps at 700 K that allows for the SH3 domain to reorient freely without RDCs or AIR restraints. Following this, both ubiquitin and SH3 conformations are fixed and the alignment tensor is allowed to evolve freely to determine initial estimates from the SH3 structure ([@B38],[@B39]) (there are four RDC types available for this structure). Both molecules and tensors are then freed with the initial sampling period at 1000 K for 5 ps during which time both AIRS and RDCs are scaled from 0.1% to 100% of their final values. The backbone conformation of the segment (1--70) of ubiquitin is restrained to its initial coordinates using a harmonic potential, while the experimentally measured nOes from the free form of SH3 are used as restraints. Note that the RDCs measured in the bound form can be used to determine structural changes upon binding, as the RDC titration approach provides accurate constraints for bound forms of both partners irrespective of differences in structure and dynamics between the free and bound forms (see below). AIR restraints are used as described in the supporting information. Sampling of restraints is followed by a 5-ps sampling stage and slow cooling over 5 ps to 100 K and energy minimization. The protocol is repeated 30 times for each starting structure.

RESULTS AND DISCUSSION
======================

Chemical shift perturbation of ubiquitin and SH3
------------------------------------------------

NMR chemical shifts of protein residues are highly sensitive to changes in the local environment, and chemical shift perturbations are therefore widely used to map intermolecular interfaces of protein complexes ([@B40]) and to drive the docking of two interacting partners in order to obtain a structural model of the complex ([@B41],[@B42]). Titrations of ^15^N-labeled ubiquitin with increasing amounts of SH3-C domain at 25°C and vice versa caused a selective shift of amide proton and nitrogen resonances of several ubiquitin and SH3-C residues ([Figure 1](#F1){ref-type="fig"}), indicating a specific union between the two proteins. The most significant changes in the chemical shift of the HSQC cross-peaks of the SH3 domain can be observed at the *RT loop* (residues 18--23), the *nSrc loop* (residues 37--39), the beginning of the β-*III strand* (residues 42--44) and residues 54--58. Significant changes in the chemical shift of the HSQC cross-peaks of ubiquitin are mainly observed in two typical binding regions, namely that of Ile44 and of Gly76. Figure 1.Monitoring the binding between ubiquitin and CD2AP SH3-C by NMR chemical shift perturbations. (**A**) ^1^H and ^15^N chemical shift changes upon titrating ubiquitin into a ^15^N-labeled CD2AP SH3-C solution. Upper panel: region of ^1^H-^15^N HSQC spectra recorded at increasing amounts of ubiquitin (black to magenta). The chemical shift changes (Δδ) between the first and last titration point \[Equation ([6](#M6){ref-type="disp-formula"})\] are presented in the bottom panel. (**B**) ^1^H and ^15^N chemical shift changes upon titrating SH3-C into a ^15^N-labeled ubiquitin solution. Upper and lower panels as in (A). Blue solid lines indicate the mean chemical shift changes that were used to define the active SH3 and ubiquitin residues used in HADDOCK. (**C**) Changes in chemical shift, Δδ, of selected residues in ^15^N-labeled SH3 upon addition of unlabeled ubiquitin: black Trp44; red Thr38; green Asp21; blue Glu20; cyan Asn19; magenta Thr18. (**D**) Changes in chemical shift, Δδ, of selected residues in ^15^N-labeled ubiquitin upon addition of unlabeled CD2AP SH3-C: black Leu73; red His68; green Gly47; blue Phe45; cyan Arg42.

The SH3-Ubiquitin complex is in fast exchange with the free forms of the partners as shown from the chemical shift titration in [Figure 1](#F1){ref-type="fig"}A and B (upper panels). Thus, no significant line broadening of the resonances is observed during the titration. A *K*~d~ of 132 ± 13 μM was determined ([Figure 1](#F1){ref-type="fig"}C, D) on the basis of a simultaneous fit of the combined ^1^H^N^ and ^15^N shifts of residues 18, 19, 20, 21, 38, and 44 (SH3) to titration of added ubiquitin, and 42, 45, 47, 68 and 73 (Ubiquitin) to titration of added SH3. The affected sites on SH3 are identified from the extent of the chemical shift perturbations upon addition of ubiquitin and vice versa ([Figure 1](#F1){ref-type="fig"}A and B, lower panels), and these sites were transformed into ambiguous intermolecular distance restraints (AIRs, see 'Methods' section in [Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkp211/DC1)). The program HADDOCK ([@B37]) was used to calculate the structure of the complex on the basis of these restraints. The 200 lowest energy structures were refined in a shell of water, and one representative structure of each of 10 identified clusters were selected (see [Supplementary Data, Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkp211/DC1)) for further refinement of the conformation of the complex using RDCs measured of both proteins in the bound forms.

Titration of RDCs for ubiquitin and SH3 in the protein--protein complex
-----------------------------------------------------------------------

SH3 was uniformly isotopically labeled ^13^C and ^15^N, and ubiquitin was uniformly ^15^N labeled. This allowed the use of isotopically filtered RDC measurements (see 'Materials and Methods' section) such that couplings from both partners were measured in three mixtures (*m*~1~, *m*~2~ and *m*~3~) of the two components. ^15^N--^1^H^N^ RDCs were measured in ubiquitin and ^15^N--^1^H^N^, ^13^C′--^1^H^N^, ^13^C′--^13^C^α^ and ^13^C^α^--^1^H^α^ were measured for SH3. This labeling scheme was adopted to simplify spectral analysis when RDCs are measured from both partners in the same sample, an integral part of the method developed here ([@B22]). These RDCs were also measured in independently aligned free forms of both molecules (samples *m*~0,ubi~ and *m*~0,sh3~). For each partially aligned sample, *p*~bound~ was determined from the ratios of intensities (volumes) of resonances in ^1^H--^15^N HSQC spectra containing peaks from both SH3 and ubiquitin. The mixtures (*m*~1~, *m*~2~ and *m*~3~) were thus estimated to represent *p*~bound~ values of (0.44, 0.75 and 0.84) for SH3 and (0.79, 0.61 and 0.49) for ubiquitin.

Correlation plots of ^1^*D*~NH~ measured in the free forms of SH3 and ubiquitin compared to values measured at the other three mixtures are indicative of differently oriented alignment tensors in the free and bound forms of both proteins, in particular SH3 ([Figure 2](#F2){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). RDCs measured in free forms and mixtures of SH3 and ubiquitin were compared to known structures of the two proteins \[pdb code~~s~~: 1D3Z ([@B43]) for ubiquitin and the RDC refined structure of SH3\] using the program MODULE ([@B44]). All data sets fit reasonably well to these structures, as illustrated in Figures S2 and S3 in [Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkp211/DC1) and [Table 1](#T1){ref-type="table"}. Table 1.Alignment tensors of different experimental mixturesFree[^a^](#TF1){ref-type="table-fn"} Ubi*m*~3~*m*~2~*m*~1~Bound[^b^](#TF2){ref-type="table-fn"} UbiBound[^c^](#TF3){ref-type="table-fn"} Ubi refSH3/Ubi[^d^](#TF4){ref-type="table-fn"} refBound[^e^](#TF5){ref-type="table-fn"} SH3 refBound[^f^](#TF6){ref-type="table-fn"} SH3*m*~3~*m*~2~*m*~1~Free[^g^](#TF7){ref-type="table-fn"} SH3*A*~a~ (10^−4^)12.012.212.613.213.313.7 ± 0.212.9 ± 0.112.4 ± 0.111.810.010.0--14.7--25.3*A*~r~ (10^−4^)1.102.12.44.54.54.3 ± 0.13.7 ± 0.13.0 ± 0.13.00.31.2--6.7--7.3α (°)124--24--29--37--40--------126--126--144--82--107β (°)14838394547------54116108150148γ (°)1737.4102022------87--99--104--5--28[^1][^2][^3][^4][^5][^6][^7] Figure 2.Correlation plots of experimental ^15^N--^1^H^N^ RDC data sets. (**A--C**) RDCs in the free form of SH3 versus the RDCs in mixture *m*~1~ (A), *m*~2~ (B) and *m*~3~ (C). (**D--F**) RDCs in the free form of ubiquitin versus RDCs in mixture *m*~1~ (D), *m*~2~ (E) and *m*~3~ (F).

In the case of the RDCs emanating from mixtures of *D*~*ij*~^bound^ and *D*~*ij*~^free^, the effective alignment tensor results from a linear combination of the free and bound alignment tensors. The effective tensors resulting from these different combinations can vary significantly in terms of rhombicity and orientation (simulated data shown in [Table S2 in Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkp211/DC1)). It is important to note that the fit of the known structure to the RDCs from any mixture will be equally good, so that the presence of a contribution from the unbound form cannot be identified on the basis of the data reproduction, but as we will see below, these effects can strongly influence the final conformation of the complex. It is therefore important to accurately estimate the true values of the bound RDCs. The procedures we have developed to achieve this are presented in the 'Theoretical aspects' section above and the results described below.

Extraction of bound form RDCs for ubiquitin and SH3
---------------------------------------------------

A total of 1168 experimentally measured RDCs are used to determine the four global scaling parameters *λ~i~* and the bound-form values of *both* proteins are extrapolated from the linear build-up for each individual RDC. This approach involves fixing the scaling factor (*λ*~3~) for one of the three mixtures (*m*~3~) of measured couplings, while RDCs from the remaining mixtures are used to simultaneously determine optimal values for *λ*~1~, *λ*~2~, *λ*~0,ubi~ and *λ*~0,sh3~. The scaling factors are applied to data measured on both proteins simultaneously such that while *λ*~1~ corresponds to the required scaling for the equilibrium with majority free form of SH3, it also corresponds to the required scaling for the equilibrium with majority of bound form ubiquitin. This adjustment is independent of which scaling factor is initially fixed. Comparison of the optimal scaling parameters extracted using this approach with the ratio of the overall alignment as estimated from the ^2^H splitting indicates very good similarity between the independently estimated values ([Table 2](#T2){ref-type="table"}). The approach can therefore be applied with confidence for alignment media or experimental conditions for which the ^2^H splitting does not reflect a linear measure of the effective protein alignment. We note that in cases where the level of alignment is accurately known, an analogous procedure can be applied to adjust the molar ratio of the components for each mixture. Table 2.Comparison of D~2~O scaling parameters with those extracted from fitsSample*m*~1~*m*~2~*m*~3~*m*~0,sh3~*m*~0,ubi~Concentration of  SH3 (mM)0.900.830.781.000.00Concentration of  ubiquitin (mM)0.501.031.330.000.50*p*~bound~ for SH30.440.750.840.00--*p*~bound~ for ubiquitin0.790.610.49--0.00Experimental D~2~O  splittings (Hz)[^a^](#TF8){ref-type="table-fn"}29 (1.16)25 (1.00)25 (≡ 1)18 (0.72)37 (1.48)λ*~m~*1.2331.027≡ 10.6431.643[^8]

[Figure 3](#F3){ref-type="fig"} shows the dependence of arbitrarily selected couplings on *p*~bound~ for both SH3 and ubiquitin after optimization of *λ*~1~, *λ*~2~, *λ*~0,ubi~ and *λ*~0,sh3~ relative to *λ*~3~. Linearity of RDCs with respect to *p*~bound~ is very clearly observed throughout the molecule. This linearity is expected to exist irrespective of the local structure and dynamics experienced in the two forms, as long as the exchange can be described in terms of a two-state system and that it is fast on the chemical shift and dipolar coupling time scale. To further demonstrate the available precision of this analysis, one-tenth of all RDCs were randomly removed from the total data set and retained for comparison with predicted values derived from the remaining RDCs. Comparisons of experimental and predicted data agree within experimental error for all RDCs ([Figure 4](#F4){ref-type="fig"}). This figure also illustrates the relative precision of the different coupling types relative to their experimental range, with slightly higher dispersion for the smaller ^13^C′--^1^H^N^ and ^13^C′--^13^C^α^ couplings. This analysis can be used to estimate the precision of the extrapolated bound-form couplings in the range of 0.5--1.0 Hz, that combines all contributions to uncertainty, including sample preparation, experimental uncertainty, analytical extraction of the RDCs and extrapolation of the bound-form values and estimation of the fraction of free and bound forms. Figure 3.Plots of linearly changing RDCs with respect to population of the bound state (*x*-axis). The fully bound values (open circles) represent the values determined by optimization of Equation ([3](#M3){ref-type="disp-formula"}). The remaining values are experimental values, adjusted by optimizing the linearity of the slope by scaling the four parameters *λ*~1~, *λ*~2~, *λ*~0,ubi~ and *λ*~0,sh3~ relative to *λ*~3~. Five sites are shown for each RDC type \[(**A--D**) SH3, E Ubiquitin). The selected sites show fits of average quality. Figure 4.Cross-validation of RDC titration analysis. (**A--E**) Back-calculated points from linear fitting approach shown in Figure 3. A total of 120 different RDCs were removed from the analysis, back-calculated (*y*-axis) and compared to the experimental value (*x*-axis). The results of three such calculations are shown in each case (each color represents one of the three analyses) (A) SH3 ^15^N-^1^H^N^ RDCs, B -- SH3 ^13^C^α^-^1^H^α^ RDCs, C -- SH3 ^13^C′-^13^C^α^ RDCs, D -- SH3 ^13^C′-^1^H^N^ RDCs, E- Ubiquitin ^15^N-^1^H^N^ RDCs.

Refinement of the complex using bound form RDCs for ubiquitin and SH3
---------------------------------------------------------------------

Following this procedure, the eigenvalues of the alignment tensors of the scaled free and bound forms represent expected values for a common level of alignment for the two proteins. Comparison of the extrapolated bound form RDCs (open circles in [Figure 3](#F3){ref-type="fig"}) with known structures of the free form proteins ([Table 1](#T1){ref-type="table"}) shows that the optimal bound form tensor eigenvalues are slightly smaller for SH3 than for Ubiquitin (*A*~a~≈13.3 × 10^−4^, *A*~r~ ≈ 4.5 × 10^−4^, compared to 11.8 × 10^−4^ and 3.8 × 10^−4^). This comparison may be biased by a dependence both on angular sampling of RDC-relevant vectors in the two proteins and on the quality of the structures used to determine the tensors ([@B45],[@B46]) (a high-resolution RDC-refined structure of ubiquitin---1D3Z and the free form structure of SH3 refined with the four types of RDCs measured on the aligned free form). We therefore carried out a control calculation, wherein the two structures were refined against independent tensors. This leads to optimal tensors for the two refined protein structures of *A*~a~ = 13.7 × 10^−4^, *A*~r~ = 4.3 × 10^−4^ for ubiquitin and *A*~a~ = 12.4 × 10^−4^, *A*~r~ = 3.0 × 10^−4^ for SH3 ([Table 1](#T1){ref-type="table"}). The apparent differences in eigenvalues of both refined structures are therefore small, and we now focus on the determination of the average orientation of the two proteins in the complex.

Bound-form RDCs determined in this way for both proteins were introduced into a structure refinement procedure starting from conformers from different clusters sampled by HADDOCK using only chemical shift perturbation as intermolecular restraint. The refinement was carried out using the program Sculptor, recently interfaced into CNS, using a refinement protocol assuming a common alignment tensor for both domains whose components are simultaneously determined during the structure refinement (see 'Methods' section in [Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkp211/DC1)). The structures with the lowest target function (combining RDC, AIR and nOe violations) in the ensemble are shown in [Figure 5](#F5){ref-type="fig"}A and statistical analysis summarized in Table S3. Figure 5.Structural model of the complex between CD2AP SH3-C and ubiquitin. (**A**) Stereo representation of the ensemble of 10 lowest-energy structures derived from the RDC titration protocol (SH3-C in red, ubiquitin in blue). (**B**) Comparison between the CD2AP SH3-C:Ubiquitin (SH3-C in red, ubiquitin in blue), Sla1 SH3-3:Ubiquitin complex (PDB entry 2JTA; SH3-3 in green, ubiquitin in blue) and CIN85 SH3-C:Ubiquitin (PDB entry 2K6D; SH3 in cyan, ubiquitin in blue). Trp43 and Phe59 in CD2AP SH3-C are shown in yellow sticks and the equivalent residues in Sla1 SH3-3 and CIN85 SH3-C are shown in magenta and orange sticks, respectively. The SH3:Ubiquitin complexes were superimposed on the backbone atoms of residues 4--71 of ubiquitin (RMSD of 0.74 and 1.32 Å for Sla1 and CIN85 to CD2AP, respectively).

The resulting structure of the complex is importantly different from the Sla1 SH3-3:Ubiquitin, ([@B25],[@B26]) and the CIN85 SH3-C:Ubiquitin structure ([@B47]). A key affinity and specificity determinant for ubiquitin binding was appointed to Phe409 of Sla1, located at the heart of the hydrophobic interface in the SH3--ubiquitin complex. Other SH3 domains with a tyrosine at this position were found to be incompetent to bind ubiquitin ([@B25]). Moreover, the Phe409 to Tyr mutation in Sla1 was shown to abolish ubiquitin binding confirming the key role of the phenylalanine residue at this position ([@B25]). In our structure, the corresponding phenylalanine residue in the CD2AP SH3-C:Ubiquitin complex is placed at the edge of the binding interface ([Figure 5](#F5){ref-type="fig"}B). In contrast to Sla1 SH3-3, the replacement of this phenylalanine in CD2AP SH3-C by a tyrosine does not abolish ubiquitin binding as monitored by fluorescence, ITC and NMR experiments (data not shown), thus confirming the correctness of our model and indicating that in this case the phenylalanine does not play a key role for the affinity and specificity of ubiquitin binding. The intriguing question that remains is which residues and/or which region of a particular ubiquitin-binding SH3 domain determines the mode/orientation of binding to ubiquitin and whether this difference in binding mode is somehow related to a difference in function. Further progress in this direction will require a more detailed structural and functional study of these complexes, but we note that the recent observation of alternative binding modes present in the formation of this complex already provides evidence for transient encounter complexes that are sampled during the course of this interaction ([@B48]).

Comparison to a determination of RDCs from weak complexes with standard protocols
---------------------------------------------------------------------------------

The true values of the bound form RDCs are not known *a priori*, precluding direct assessment of the relative accuracy of this approach compared to a classical extrapolation from a single mixture. Nevertheless we are able to compare experimentally measured values from one of the mixtures. All ^15^N--^1^H^N^ RDCs measured in SH3 were therefore removed from mixture *m*~3~, the analysis was repeated and experimental and predicted values were compared ([Figure S6B in Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkp211/DC1)). We have compared this analysis to a prediction of SH3 RDCs from mixture *m*~3~ on the basis of values measured in *m*~0~ and *m*~1~ using a standard extrapolation: *D*~*ij*~^*m*~3~^ = (λ~1~ *p*~3~ *D*~*ij*~^*m*~1~^ − λ~0,\ sh3~ (*p*~3~ − *p*~1~)*D*~*ij*~^free^)/λ~3~ *p*~1~. The populations *p* are assumed to be accurately known in both cases and in this case the scaling terms *λ* represent the experimentally measured D~2~O splitting ([Table 2](#T2){ref-type="table"}). This case is equivalent to a single mixture where over 50% of SH3 molecules are in the complex. As shown in Figure S6, the ability to reproduce experimental RDCs is significantly improved using the RDC titration approach. The two-point approach, that is directly analogous to standard extrapolation methods based on measurement of a single mixture, suffers from two drawbacks: the combination of experimental errors of the two experimental points that results in random fluctuations of the predicted RDCs and the uncertainty in the actual alignment level that scales all couplings by an unknown systematic error. The combination of these errors results in a poor reproduction of experimental data, and indicates that this kind of approach is likely to provide highly inaccurate RDCs for refinement of molecular orientation. Neither of these sources of error can be corrected without further measurements, and both sources are minimized and at least partially corrected in the RDC titration approach. The possible consequences of these errors in terms of molecular structure are discussed below.

Refinement against RDCs measured in nonsaturated conditions
-----------------------------------------------------------

The real importance of determining accurate alignment tensors for the precise determination of weakly interacting proteins is illustrated in [Figure 6](#F6){ref-type="fig"}, where data were simulated from the experimentally determined alignment tensors of free and complexed SH3 and Ubiquitin, and used as restraints to orient the partner proteins. Three conditions of incomplete saturation were simulated: 90% saturation for both proteins, 80% saturation and 70% saturation. In each case, the remainder of the protein was assumed to be in its free form. The optimal configurations of the complexes, determined after orientation of the partner proteins such that their effective alignment tensor axes were coaxial and intermolecular contacts best reproduced, are shown in [Figure 6](#F6){ref-type="fig"}. The orientation of the partners very clearly changes, and is evidently incorrect even for complexes refined with data emanating from samples containing relatively high populations of complexed relative to free form. When the dissociation constant is sufficiently weak, it is therefore extremely risky to exploit RDC data sets from a single mixture even when the data are measured in the range of 0.7 \< *p*~bound~ \< 1.0, unless one can be certain of the exact population of free protein. Figure 6.Effect of non-saturation on effective alignment and orientation of the SH3-Ubiquitin complex. Data were simulated from the bound and free states of ubiquitin and SH3 and mixed in ratios of 1.00:0.0 (**A**), 0.9:0.1 (**B**), 0.8:0.2 (**C**) and 0.7:0.3 (**D**). The relative orientation was determined by aligning the axes of the effective alignment tensors for the two domains. Right-hand panels represent a rotation of 90° about the vertical axis with respect to the left-hand panels. The ubiquitin domain is held fixed for the purposes of comparison in the figure. The alignment tensors for SH3 and Ubiquitin are respectively given by (A) *A*~a~ = 12.2 × 10^−4^, *A*~r~ = 3.2 × 10^−4^; *A*~a~ = 13.3 × 10^−4^, *A*~r~ = 4.3 × 10^−4^; (B) *A*~a~ = 10.9 × 10^−4^, *A*~r~ = 2.3 × 10^−4^; *A*~a~ = 12.8 × 10^−4^, *A*~r~ = 4.0 × 10^−4^; (C) *A*~a~ = 10.0 × 10^−4^, *A*~r~ = 2.0 × 10^−4^; *A*~a~ = 12.4 × 10^−4^, *A*~r~ = 3.7 × 10^−4^; (D) *A*~a~ = 9.6 × 10^−4^, *A*~r~ = 3.0 × 10^−4^; *A*~a~ = 12.0 × 10^−4^, *A*~r~ = 3.4 × 10^−4^. Differences in orientation relative to the fully bound form (A) can be measured by the differences in the Euler rotations of the alignment tensor axes for the two molecules: (B) δα = 10°, δβ = 10°, δγ = 2°; (C) δα = 32°, δβ = 20°, δγ = 7°; (D) δα = 54°, δβ = 29°, δγ = 12°.

Impact of RDC titration on the accuracy of molecular interfaces in weak complexes
---------------------------------------------------------------------------------

Understanding the interaction structure of an organism\'s proteome is one of the key objectives of the many genomic and proteomic initiatives realized over recent decades. A complete understanding of molecular biology can only be derived from an atomic-level description of molecular interactions that control many cellular processes and are crucial for biological function. Weak molecular interactions are important for a vast range of cellular events, such as transcription and replication, signal transduction, transient formation of encounter complexes and assembly of protein complexes. NMR spectroscopy is the technique of choice for studying weak protein--protein, protein--nucleic acid or nucleic acid--nucleic acid interactions, characterizing transiently populated molecular complexes at atomic resolution. RDCs are powerful constraints that can be used to describe intermolecular orientation, but great care needs to exercised when using these constraints for the study of weakly interacting proteins. In this study we demonstrate that even in the case of weakly populated free forms of either protein, incorrect orientational information can be aliased into inaccurate position of the proteins in the subsequently determined complex, a scenario that is not detectable from the raw RDC data. The importance of this observation should not be underestimated for the understanding of molecular interaction. The example described here clearly demonstrates that under experimental conditions where only 80% of the protein is in the complex, the relative orientation of the entire protein can be incorrectly determined, incurring errors of up to 40--50°. These errors cannot be detected, giving back-calculated restraints that are in perfect agreement with the data, unless the titration procedure introduced here is applied. The consequences of this source of error are important, potentially leading to completely erroneous interpretation of the physical forces controlling molecular association and dissociation, for example, electrostatic, hydrophobic or hydrogen bonding interactions, quite simply because the wrong amino acids will be aligned in the opposing interfaces.

CONCLUSIONS
===========

We have developed a robust approach to the exploitation of the unique orientational information available from RDCs in the case of weak interaction and rapid exchange between free and bound forms. We demonstrate that the measurement of RDC changes upon titration of one partner into the equilibrium mixture leads to accurate determination of bound forms for both partners that are otherwise experimentally unattainable. We further develop analytical methods that guarantee the robustness of the approach by accurately adjusting the effective level of alignment of bound and free forms at all titration points. The method is applicable to a large number of proteins that can be studied by classical chemical shift perturbation, as long as both proteins and complex can be successfully aligned in the same medium, and that the complex can also be aligned. This approach provides complementary conformational restraints to those available from intermolecular contact restraints within a reasonable experimental period (3--4 days). We expect that this technique will extend the already remarkable and unique ability of NMR to determine the binding modes of weak complexes and expect this approach to contribute further to our understanding of diverse interactomes and thereby the molecular basis of cellular processes in different organisms.
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[Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkp211/DC1) are available at NAR Online.
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[^1]: ^a^ Tensor eigenvalues (scaled by appropriate λ value) resulting from fit of experimental RDCs measured from free Ubiquitin to the structure 1d3z.

[^2]: ^b^ Tensor eigenvalues resulting from fit of fully bound Ubiquitin RDCs.

[^3]: ^c^ Simultaneous refinement of the structure of 1d3z and alignment tensor eigenvalues using RDCs from fully bound Ubiquitin.

[^4]: ^d^ Simultaneous refinement of the complex structure of ubiquitin/SH3 complex using RDCs from fully bound forms of Ubiquitin and SH3.

[^5]: ^e^ Simultaneous refinement of the structure of SH3 and alignment tensor eigenvalues using RDCs from fully bound form of SH3.

[^6]: ^f^ Fit of experimental RDCs from bound form of SH3 to RDC-refined structure of free-form SH3.

[^7]: ^g^ Simultaneous refinement of SH3 (pdb code 2JTE) and alignment tensor eigenvalues using RDCs from SH3 alone.

[^8]: ^a^Number in parentheses indicates the scaled splitting relative to *m*~3~ mixture, for comparison with λ*~m~* values scaled to λ~3~.
